Skip to main content
OpenTrials
Completed

NCT Number: NCT01984216

Billroth II Versus Roux-en-Y for the Gastrojejunostomy in the Pancreatoduodenectomy

The purpose of this study is to compare the safety and superiority of Roux-Y versus Billroth II gastrojejunostomy reconstruction on delayed gastric emptying after pancreatoduodenectomy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Complejo Hospitalario de Navarra

Pamplona, Navarre, 31008, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Consecutive series of patients undergoing pancreaticoduodenectomy (PD).
  • Given informed consent.

Exclusion criteria

  • Inability to perform pancreatogastrostomy.
  • Resection of other organs, except the superior mesenteric-portal vein.
  • Previous gastric surgery.
  • Preoperative gastric or duodenal obstruction.
  • Previous complex abdominal surgery.

Treatment and study plan

Roux-en-Y for the gastrojejunostomy reconstruction

Procedure

Billroth II for the gastrojejunostomy reconstruction

Procedure

Primary outcomes

  1. Incidence of delayed gastric emptying (DGE)

    Time frame: 30 day after surgery

Sponsors and collaborators

Lead sponsor

Fundacion Miguel Servet

Other

Registry information

Official study title

Billroth II Versus Roux-en-Y for the Gastrojejunostomy Reconstruction in the Pancreatoduodenectomy: a Randomized Controlled Study

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Nov 14, 2013
Registry last updated
Aug 29, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.